Medication info
Heuonseu Amoxiclara Tablet (Amoxicillin Hydrate · Clavulanate Potassium)

Heuonseu Amoxiclara Tablet (Amoxicillin Hydrate · Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Heuonseu Co., Ltd.
Appearance
White or almost white oval film-coated tablets
Packaging
100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 201307118 · Approved 2013.04.30 · Insurance code 670606520

Summary

Main use
Treatment of respiratory and ear, nose, and throat, genitourinary, skin and soft tissue, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. ○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or higher. Creatinine clearance Dosage and administration 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)
Child dose
○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. - Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Heuonseu Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat, genitourinary, skin and soft tissue, bone, and dental infections

  • Acute bronchitis
  • chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscesses
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
View approved original text

This medication is used for the treatment of various infections caused by different bacteria. It is effective for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, and lung abscesses. It is also used for infections such as tonsillitis, sinusitis, and otitis media. It is suitable for urinary tract infections such as cystitis, urethritis, pyelonephritis, as well as pelvic infections and gonorrhea. It provides broad treatment for skin and soft tissue infections, boils or abscesses, soft tissue inflammation, and wound infections. It is also effective for osteomyelitis and dental infections, helping to improve a variety of infections.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. ○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or higher. Creatinine clearance Dosage and administration 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)

Child dose

○ Adults and children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. - Children: Reduce the dose in the same manner.

Precautions

This medication should not be used in patients with allergies to specific ingredients, especially those who have previously experienced hypersensitivity to penicillin class drugs. Also, patients with infectious mononucleosis or lymphocytic leukemia should be cautious when taking this medication as it may increase the risk of rash. Patients with liver function problems may experience a recurrence of symptoms if they take this medication, so caution is required. Patients with decreased liver function or severe kidney disease should use the medication carefully, adjusting the dose and intervals due to potentially elevated drug concentrations. Patients with an allergic constitution or those who often present with symptoms such as bronchial asthma or skin rashes should consult a physician before taking this medication. Patients who have difficulty with oral intake, the elderly, or those in poor general condition are at risk for bleeding due to vitamin K deficiency, requiring caution. Patients with gastrointestinal diseases may experience decreased absorption of the medication, which could reduce its effectiveness. This medication can cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain. In severe cases, serious conditions like pseudomembranous colitis may occur; if any abnormal symptoms arise, the medication should be discontinued immediately and medical attention sought. Liver function abnormalities have also been reported, particularly in elderly patients or those on prolonged treatment, so regular liver function tests are advisable. Rarely, serious allergic reactions such as rashes, anaphylaxis, and hematological abnormalities can occur, so if symptoms like rash or breathing difficulties arise, the medication should be stopped immediately and medical assistance sought. This medication can also impact kidney function, and those with kidney abnormalities require regular testing and should discontinue use if any signs occur. While using antibiotics, the balance of intestinal flora may be disrupted, leading to infections like candidiasis or stomatitis; thus, consultation with a physician should be sought if symptoms occur. Bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B complex deficiency may also arise; caution is necessary with prolonged use. This medication can interact with other drugs, so individuals taking other medications must inform their healthcare provider, particularly when combined with anticoagulants or specific antibiotics. Pregnant women or those who may become pregnant must consult a physician before using this medication, and especially should not use it during the first three months of pregnancy. In breastfeeding cases, this medication may be partially transferred to breast milk, potentially causing diarrhea or skin rashes in infants; if abnormal symptoms arise, use should be stopped. Use in children under 12 years or those weighing less than 40 kg is not recommended. Elderly patients may experience side effects more readily due to decreased physiological functions; therefore, they should use the medication cautiously, adjusting the dose and intervals. This medication may affect certain clinical test results, such as urine sugar tests; healthcare providers should be informed during testing. In cases of overdose, symptoms such as gastrointestinal issues, renal dysfunction, or allergic reactions may occur; immediate discontinuation and emergency care are necessary.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, severe colitis with blood in stool, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itchiness, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, dyspnea with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, anxiety, restlessness, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, antidystonic effects, fever, cloudy consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B group deficiency, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, decreased urine output, interstitial cerebral convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is packaged to prevent moisture and must be stored in a cool, dry place below 25 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

White or almost white oval film-coated tablets

Package unit

100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.